AMINOSYN II IN DEXTROSE INJECTION SOLUTION

国: カナダ

言語: 英語

ソース: Health Canada

有効成分:

L-ISOLEUCINE; L-LEUCINE; L-LYSINE (L-LYSINE ACETATE); METHIONINE; L-PHENYLALANINE; L-THREONINE; TRYPTOPHAN; L-VALINE; L-ALANINE; L-ARGININE; L-ASPARTIC ACID; GLUTAMIC ACID; GLYCINE; HISTIDINE; L-PROLINE; SERINE; N-ACETYL-L-TYROSINE; DEXTROSE

から入手可能:

HOSPIRA HEALTHCARE ULC

ATCコード:

B05BA10

INN（国際名）:

COMBINATIONS

投薬量:

280MG; 425MG; 446MG; 73MG; 126MG; 170MG; 85MG; 212MG; 422MG; 432MG; 298MG; 314MG; 212MG; 128MG; 307MG; 225MG; 115MG; 20G

医薬品形態:

SOLUTION

構図:

L-ISOLEUCINE 280MG; L-LEUCINE 425MG; L-LYSINE (L-LYSINE ACETATE) 446MG; METHIONINE 73MG; L-PHENYLALANINE 126MG; L-THREONINE 170MG; TRYPTOPHAN 85MG; L-VALINE 212MG; L-ALANINE 422MG; L-ARGININE 432MG; L-ASPARTIC ACID 298MG; GLUTAMIC ACID 314MG; GLYCINE 212MG; HISTIDINE 128MG; L-PROLINE 307MG; SERINE 225MG; N-ACETYL-L-TYROSINE 115MG; DEXTROSE 20G

投与経路:

INTRAVENOUS

パッケージ内のユニット:

1000ML

処方タイプ:

Ethical

治療領域:

CALORIC AGENTS

製品概要:

Active ingredient group (AIG) number: 1850889007; AHFS:

認証ステータス:

CANCELLED POST MARKET

承認日:

2012-08-03

製品の特徴

PRESCRIBING INFORMATION
AMINOSYN® II IN DEXTROSE INJECTION
AMINOSYN® II WITH ELECTROLYTES IN DEXTROSE INJECTION
AMINOSYN® II WITH ELECTROLYTES IN DEXTROSE INJECTION
WITH CALCIUM
NUTRIMIX® DUAL CHAMBER CONTAINERS
Nutritive with and without Electrolyte Supplements for Intravenous
Infusion
Hospira Healthcare Corporation
DATE OF PREPARATION:
5400 Côte-de-Liesse
May 28, 2004
Town of Mount Royal (QC), CANADA
H4P 1A5
Control#: 091791, 091794, 091796, 091797, 091802, 091806
- 2 -
PRESCRIBING INFORMATION
NAME OF DRUGS
AMINOSYN® II IN DEXTROSE INJECTION
AMINOSYN® II WITH ELECTROLYTES IN DEXTROSE INJECTION
AMINOSYN® II WITH ELECTROLYTES IN DEXTROSE INJECTION
WITH CALCIUM
NUTRIMIX® DUAL CHAMBER CONTAINERS
THERAPEUTIC OR PHARMACOLOGICAL CLASSIFICATION
Nutritive with and without Electrolyte Supplements for Intravenous
Infusion
CLINICAL PHARMACOLOGY
Total parenteral nutrition consists of appropriate amino acids,
electrolytes, trace metals, vitamins
and an energy source. This may be accomplished by administering
AMINOSYN® II (amino acids)
with or without electrolytes, fat emulsion plus concentrated dextrose,
vitamins and trace metals.
AMINOSYN® II (an amino acid injection) with or without Electrolytes
in Dextrose Injection with or
without Calcium obtained after thoroughly mixing the contents of the
two chambers provides
carbohydrate calories and amino acids to promote protein synthesis and
wound healing, to reduce
the rate of endogenous protein catabolism and to minimize liver
glycogen depletion.
INDICATIONS AND CLINICAL USES
1. PERIPHERAL VEIN ADMINISTRATION
AMINOSYN® II 3.5% in 5% Dextrose Injection and AMINOSYN® II 3.5% M
(amino acid injection
3.5% with maintenance electrolytes) in 5% Dextrose Injection are
indicated for peripheral vein
infusion as a source of nitrogen in the intravenous treatment of acute
surgical patients with
adequate store of body fat, in whom, for short periods of time, oral
nutrition cannot be tolerated or
is not desirable. In such instances, the patients' energy needs are
met from their ow